Literature DB >> 15135351

Investigation of serum IGF-I levels amongst diabetic and non-diabetic cats.

S R Starkey1, K Tan, D B Church.   

Abstract

Since insulin-like growth factor-I (IGF-I) was first discovered as a mediator of glucose homeostasis, it has been extensively investigated in diabetes research in humans, rodents and primates. To date, however, relatively little work has been carried out on this hormone in the cat, despite the pathophysiological similarities between human and feline diabetes mellitus, as well as the relatively common nature of the disease in cats. This study reports on the IGF-I concentrations of 42 insulin treated diabetic cats and 25 normal cats. Diabetic subjects were grouped according to length of insulin treatment as either short, medium or long term. Analysis of variance (ANOVA) and Fischer's pair-wise comparisons revealed that mean IGF-I levels in short-term diabetic cats were significantly lower than those in normal cats whilst mean levels in long-term diabetics were significantly higher. The direction and extent of these alterations may have implications for our understanding of the pathophysiology of feline diabetes mellitus and for the use of this hormone in the diagnosis of acromegaly in diabetic cats.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135351     DOI: 10.1016/j.jfms.2004.01.002

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  4 in total

1.  Evaluation of IGF-I levels and serum protein profiles of diabetic cats and dogs.

Authors:  Gulay Ciftci; Gul Fatma Yarim
Journal:  J Vet Sci       Date:  2011-12       Impact factor: 1.672

2.  Pasireotide for the Medical Management of Feline Hypersomatotropism.

Authors:  C J Scudder; R Gostelow; Y Forcada; H A Schmid; D Church; S J M Niessen
Journal:  J Vet Intern Med       Date:  2015-05-06       Impact factor: 3.333

3.  Acromegaly in a non-diabetic cat.

Authors:  Federico Fracassi; Margherita Salsi; Federica Sammartano; Stefano Bo; Hans S Kooistra
Journal:  JFMS Open Rep       Date:  2016-04-25

4.  Serum N-Terminal Type III Procollagen Propeptide: An Indicator of Growth Hormone Excess and Response to Treatment in Feline Hypersomatotropism.

Authors:  S V Keyte; P J Kenny; Y Forcada; D B Church; S J M Niessen
Journal:  J Vet Intern Med       Date:  2016-07-18       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.